Novo – Parkinson’s Cell Therapy Transfer

Summary Novo Nordisk has transferred a Parkinson’s disease cell therapy program to Cellular Intelligence, reflecting continued asset recycling and lifecycle extension within the advanced cell therapy ecosystem. What Happened Cellular Intelligence, an AI-focused biotechnology company, acquired rights to a discontinued Parkinson’s disease cell therapy program…